Drugs / ALBITIAZOLIUM
ALBITIAZOLIUM
also known as
SAR97276A · ALBITIAZOLIUM BROMIDE · Albitiazolium cation · Albitiazolium ion · Bromure d'albitiazolium · Bromuro de albitiazolio · SAR-97276
Trials 2 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT01445938 | Oct 2011 → Jan 2012 | malaria | Sanofi | Terminated | No outcome recorded |
| Phase 2 | NCT00739206 | Aug 2008 → Jun 2009 | malaria | Sanofi | Terminated | No outcome recorded |
Evidence & citations 11 cited values
Every value below carries the sentence it was read from. 4 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | ALBITIAZOLIUM | ChEMBL registry synonym — accepted as the source's own label CHEMBL1183040 ↗ |
| Known as | ALBITIAZOLIUM BROMIDE | ChEMBL registry synonym — accepted as the source's own label CHEMBL1183040 ↗ |
| Known as | Albitiazolium cation | ChEMBL registry synonym — accepted as the source's own label CHEMBL1183040 ↗ |
| Known as | Albitiazolium ion | ChEMBL registry synonym — accepted as the source's own label CHEMBL1183040 ↗ |
| Known as | Bromure d'albitiazolium | ChEMBL registry synonym — accepted as the source's own label CHEMBL1183040 ↗ |
| Known as | Bromuro de albitiazolio | ChEMBL registry synonym — accepted as the source's own label CHEMBL1183040 ↗ |
| Known as | SAR-97276 | ChEMBL registry synonym — accepted as the source's own label CHEMBL1183040 ↗ |
| Known as | SAR97276A | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01445938 ↗ |
| Modality | Small molecule | “the choline analogue SAR97276A is a novel chemical entity” PMID 28472957 ↗ May 2017 |
| Route | Intramuscular | “given either intramuscularly (IM) (0.18 mg/kg) or intravenously (IV) (0.14 mg/kg)” PMID 28472957 ↗ May 2017 |
| Route | Intravenous | “given either intramuscularly (IM) (0.18 mg/kg) or intravenously (IV) (0.14 mg/kg)” PMID 28472957 ↗ May 2017 |